AlloVir, Inc. (ALVR) Financials
Stock symbol ALVR is outdated, potentially delisted? Maybe it is available on other exchange?
ALVR Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| Dec. 31, 2023 | 190.8 million | 45.0 million |
| Sept. 30, 2023 | 248.3 million | 53.0 million |
| June 30, 2023 | 282.7 million | 53.6 million |
| March 31, 2023 | 244.0 million | 50.5 million |
ALVR Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| Dec. 31, 2023 | -30.7 million | 10.0 million |
| Sept. 30, 2023 | -34.5 million | 10.5 million |
| June 30, 2023 | -27.1 million | 10.3 million |
| March 31, 2023 | -32.1 million | 10.0 million |
ALVR Net Income
No data available :(
ALVR Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| Dec. 31, 2023 | 183.9 million | - | 27.4 million |
| Sept. 30, 2023 | 213.3 million | - | 32.9 million |
| June 30, 2023 | 246.5 million | - | 31.5 million |
| March 31, 2023 | 202.6 million | - | 33.8 million |
ALVR Shares Outstanding
ALVR Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| Dec. 31, 2023 | - | 33.2 million | 10.5 million | - |
| Sept. 30, 2023 | - | 34.2 million | 12.8 million | - |
| June 30, 2023 | - | 31.3 million | 16.0 million | - |
| March 31, 2023 | - | 30.7 million | 12.5 million | - |
ALVR Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| Dec. 31, 2023 | - | 141000 |
| Sept. 30, 2023 | - | 3.6 million |
| June 30, 2023 | - | - |
| March 31, 2023 | - | 547000 |
ALVR
Price: $9.81
52 week price:
Earnings Per Share: -20.24 USD
P/E Ratio: -0.50
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 86807
Market Capitalization: 50.9 million